| Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2 SB Biering, E Van Dis, E Wehri, LH Yamashiro, X Nguyenla, ... ACS infectious diseases 7 (8), 2337-2351, 2021 | 26 | 2021 |
| Serum mortalin correlated with α-synuclein as serum markers in Parkinson’s disease: a pilot study AP Singh, T Bajaj, D Gupta, SB Singh, A Chakrawarty, V Goyal, AB Dey, ... Neuromolecular medicine 20, 83-89, 2018 | 25 | 2018 |
| Elevated serum SIRT 2 may differentiate parkinson’s disease from atypical parkinsonian syndromes AP Singh, G Ramana, T Bajaj, V Singh, S Dwivedi, M Behari, AB Dey, ... Frontiers in Molecular Neuroscience 12, 129, 2019 | 17 | 2019 |
| Reflection on the challenges, accomplishments, and new frontiers of gene drives M VergaraMichael BioDesign Research, 2022 | 5 | 2022 |
| Crystal structure of the kinase domain of a receptor tyrosine kinase from a choanoflagellate, Monosiga brevicollis T Bajaj, J Kuriyan, CL Gee Plos one 18 (6), e0276413, 2023 | 3 | 2023 |
| Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication T Bajaj, E Wehri, RK Suryawanshi, E King, KS Pardeshi, K Behrouzi, ... RSC advances 13 (26), 17667-17677, 2023 | 2 | 2023 |
| A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication H Han, AV Gracia, JJ Røise, L Boike, K Leon, U Schulze-Gahmen, ... RSC advances 13 (16), 10636-10641, 2023 | | 2023 |
| Discovery of a reversible covalent inhibitor against Papain-like protease (PLpro) from SARS-CoV-2 virus T Bajaj, E Wehri, R Suryawanshi, K Pardeshi, E King, K Behrouzi, ... PROTEIN SCIENCE 32, 2023 | | 2023 |
| Meta-Analysis of the Expansion in the Field of Structural Biology of ABC Transporters S Kim, T Bajaj, C Chabon, E Tablante, T Kulchinskaya, TS Moon, R Bajaj BioDesign Research, 2022 | | 2022 |
| Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 T Bajaj Biophysical Journal 121 (3), 7a, 2022 | | 2022 |
| Introducing Chemically Modified Nucleotides to Improve mRNA-Based Therapeutics T Bajaj Biophysical Journal 120 (3), 136a, 2021 | | 2021 |
| Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson's disease A Singh, T Bajaj, A Dey, S Dey MOVEMENT DISORDERS 34, 2019 | | 2019 |
| Level of serum Mortalin in Parkinson's disease correlating with alpha-Synuclein: Assessment of protein marker for early detection S Dey, A Singh, T Bajaj, AB Dey MOVEMENT DISORDERS 33, S121-S121, 2018 | | 2018 |
| Assessment of Serum Mortalin in Parkinson's Disease Correlating with Alpha-Synuclein A Singh, T Bajaj, V Goyal, S Dey MOVEMENT DISORDERS 33, S106-S106, 2018 | | 2018 |
